| |
| | NEJM -- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients |
 | | Dibra, A., Kastrati, A., Alfonso, F., Seyfarth, M., Perez-Vizcayno, M.-J., Mehilli, J., Schomig, A. Effectiveness of Drug-Eluting Stents in Patients With Bare-Metal In-Stent Restenosis: Meta-Analysis of Randomized Trials. |
 | | Mehilli, J., Dibra, A., Kastrati, A., Pache, J., Dirschinger, J., Schomig, A., for the Intracoronary Drug-Eluting Stenting to Abr, (2006). |
 | | Kastrati, A., Dibra, A., Eberle, S., Mehilli, J., Suarez de Lezo, J., Goy, J.-J., Ulm, K., Schomig, A. Sirolimus-Eluting Stents vs Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease: Meta-analysis of Randomized Trials. |
| content.nejm.org /cgi/content/abstract/353/7/663 (1132 words) |
|